Final Programme - iuphar

FC04 Pharmacoepidemiology, current controversies and
opportunities
Tue 100 Determinants of antibiotics prescription among doctors in a Nigerian teaching hospital
Olayinka O Ogunleye, (Nigeria), SO Ogundele, AF Yinka-Ogunleye
Tue 101 Quality of life of arthritis rheumatology patients evaluation
PCR Palmiere, WA Souza, OMGC Vilas-Boas, EB Ferreira, Marcia HMC Podestá, (Brazil)
Tue 102 A study of the longitudinal utilization of traditional non-steroidal anti-inflammatory drugs and COX-2
selection inhibitors using a pharmacy based approach
Emilian Damian Popovici, (Romania), MG Popovici, C Trandafirescu, M Kolliali, IM Malita, LM Baditoiu
Tue 103 Pharmacological patterns of treatment in acute manic episode: A Spanish epidemiological multicentric
study
Esther Prieto, (Spain), J Galán
Tue 104 Pharmacoepidemiology as an opportunity for prognostic studies in rare diseases: The example of giant
cell arteritis and the French APOGEE cohort (Artérite en POpulation GEnérale)
Gregory Pugnet, (France), L Sailler, R Bourrel, A Sommet, JL Montastruc, M Lapeyre-Mestre
Tue 105 Effects of genetic polymorphisms of angiotensin converting enzyme in Iranian children with idiopathic
nephrotic syndrome
Parvaneh Rahimi-Moghaddam, (Iran)
Tue 106 Communication of toxic effects of drugs with polymorphism genes GST and CYP450
Natalya Shipovskaya, (Russian Federation), E Zaklyazminskaya, D Litvinov, L Shelihova
Tue 107 Clinical importance of the evidentiary level basis for drug approval in oncology
Gerald Sokol, (USA), L Loftus, B Djulbegovic, L Cantilena
Tue 108 Patients’ preferences for written information about effects and undesirable side effects of drugs
Petra A Thürmann, (Germany), V Mülders, D Simic, O Herber, D Schwappach, S Wilm
Tue 109 The feasibility of monitoring paediatric adverse drug reactions via specialist clinics
Mansour Tobaiqy, (UK), D Stewart, PJ Helms, CM Bond, AJ Lee, JHG Williams, JS McLay
Tue 110 Compounding of extemporaneous items in pharmacies in South Africa
Ilse Truter, (South Africa), M Lubbe, N Butler, D Nazer, A Gous, D Bayever, M Naidoo, P Naidoo,
V Tlala, S Putter
Tue 111 Antipsychotic prescribing to adults: A community pharmacy database analysis
Ilse Truter, (South Africa)
Tue 112 Prescribing for Parkinson’s disease in the private sector in South Africa
Ilse Truter, (South Africa),
Tue 113 The evaluation of quality of pharmacological treatment in elderly patients
Martin Wawruch, (Slovak Republic), L Kostkova, A Macugova, K Strateny, M Kuzelova, D Jezova,
A Dukat, V Kristova
Tue 114 Psychotropic drug utilization in old-adult community
N Yodu, C Peña, René Delgardo-Hernandez,(Cuba)
Tue 115 Proton pump inhibitor (PPI) or statin associated risk for Clostridium difficile associated disease (CDAD)?
Anita Zachow, (Germany), S Sonnenberg, G Haase, S Koenig, B Drewelow, SC Mueller
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 207